These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1329293)

  • 21. Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum.
    Schmidt N; Brune K; Geisslinger G
    Eur J Pharmacol; 1994 Apr; 255(1-3):245-7. PubMed ID: 8026550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization.
    Massi P; Giagnoni G; Basilico L; Gori E; Rubino T; Parolaro D
    Eur J Pharmacol; 1994 Mar; 253(3):269-74. PubMed ID: 8200420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors.
    Katsumata S; Ienaga Y; Minami M; Nakagawa T; Kanematsu K; Satoh M
    Eur J Pharmacol; 1996 Oct; 312(3):349-55. PubMed ID: 8894618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
    Löser SV; Meyer J; Freudenthaler S; Sattler M; Desel C; Meineke I; Gundert-Remy U
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):192-7. PubMed ID: 8857597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conjugated metabolites of morphine and the related compounds and their pharmacological activity (author's transl)].
    Oguri K
    Yakugaku Zasshi; 1980 Feb; 100(2):117-25. PubMed ID: 6245203
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulfation of minoxidil in keratinocytes and hair follicles and the stimulatory effect of minoxidil on the biosynthesis of glycosaminoglycans.
    Mori Y; Hamamoto T; Otomo S
    Ann N Y Acad Sci; 1991 Dec; 642():473-5. PubMed ID: 1809110
    [No Abstract]   [Full Text] [Related]  

  • 27. Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.
    Hucks D; Thompson PI; McLoughlin L; Joel SP; Patel N; Grossman A; Rees LH; Slevin ML
    Br J Cancer; 1992 Jan; 65(1):122-6. PubMed ID: 1310249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
    Baker L; Dye A; Ratka A
    Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain.
    Joshi GP
    Curr Opin Investig Drugs; 2008 Jul; 9(7):786-99. PubMed ID: 18600584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position.
    Oguri K; Yamada-Mori I; Shigezane J; Hirano T; Yoshimura H
    Life Sci; 1987 Sep; 41(12):1457-64. PubMed ID: 3041142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.
    Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1978 Dec; 64(4):607-14. PubMed ID: 215262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An attempt to structurally convert mu-selective morphine toward delta-receptor binding: dimerization based on enkephalin conformation.
    Yara H; Katagawa Y; Doi M; Ishida T; Inoue M; Yasuda M; Baba A; Iwata H; Kitamura K; Sadatome T
    Eur J Pharmacol; 1990 Jun; 188(6):359-68. PubMed ID: 2164938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
    Fürst Z; Búzás B; Friedmann T; Schmidhammer H; Borsodi A
    Eur J Pharmacol; 1993 May; 236(2):209-15. PubMed ID: 8391457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, conformation, and biological characterization of a sugar derivative of morphine that is a potent, long-lasting, and nontolerant antinociceptive.
    Arsequell G; Salvatella M; Valencia G; Fernández-Mayoralas A; Fontanella M; Venturi C; Jiménez-Barbero J; Marrón E; Rodríguez RE
    J Med Chem; 2009 May; 52(9):2656-66. PubMed ID: 19351163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons of the influence of morphine sulphate, morphine-3-glucuronide and tifluadom on social encounters in mice.
    Benton D; Smoothy R; Brain PF
    Physiol Behav; 1985 Nov; 35(5):689-93. PubMed ID: 3001798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties of newly synthesized derivatives of (-)-6 beta-acetylthionormorphine and their interactions with opioid receptors.
    Takayanagi I; Koike K; Suzuki T
    Gen Pharmacol; 1990; 21(5):605-11. PubMed ID: 2177430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical and pharmacological importance of morphine analogues.
    Fürst S; Hosztafi S
    Acta Physiol Hung; 2008 Mar; 95(1):3-44. PubMed ID: 18389996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stereostructure-activity relation of morphinics. Topology of the mu receptor and nature of the opioid pharmacophore].
    Poupaert J
    J Pharm Belg; 1989; 44(1):71-83. PubMed ID: 2542515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.